Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multi-Centre, Randomised, Double-Blind, Sham Controlled Proof of Concept Trial Evaluating the Efficacy and Safety of TenoMiR by Injection in Subjects With Lateral Epicondylitis

NCT06192927 is registered in ClinicalTrials.gov with Causeway Therapeutics as lead sponsor.

NCT NCT06192927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06192927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multi-Centre, Randomised, Double-Blind, Sham Controlled Proof of Concept Trial Evaluating the Efficacy and Safety of TenoMiR by Injection in Subjects With Lateral Epicondylitis
Lead sponsor
Causeway Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
April 10, 2024
Completion date
June 12, 2025
Enrollment
123 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

tennis elbow